APA (7th ed.) Citation

Hou, G., Harley, I. T. W., Lu, X., Zhou, T., Xu, N., Yao, C., . . . Shen, N. (2021). SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nature communications, 12(1), 135-19. https://doi.org/10.1038/s41467-020-20460-1

Chicago Style (17th ed.) Citation

Hou, Guojun, et al. "SLE Non-coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-critical MicroRNA Expression." Nature Communications 12, no. 1 (2021): 135-19. https://doi.org/10.1038/s41467-020-20460-1.

MLA (9th ed.) Citation

Hou, Guojun, et al. "SLE Non-coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-critical MicroRNA Expression." Nature Communications, vol. 12, no. 1, 2021, pp. 135-19, https://doi.org/10.1038/s41467-020-20460-1.